jRCT1052200034已完成不适用
A clinical study to evaluate the feasibility and dose delivery accuracy of modified track Dynamic WaveArc therapy
未提供0 个研究点目标入组 25 人开始时间: 2020年8月19日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 25
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
- 干预模型
- Single Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 20age old over 至 No limit（—）
- 性别
- All
入选标准
- •Left breast cancer, post surgery.
- •spinal metastases less than 3 lesions.
排除标准
- •Severe complications.
- •Mental illness.
- •Re-irradiation.
- •Dose distribution of DWA is inferior to conventional radiotherapy
结局指标
主要结局
-
Completion of treatment protocol
次要结局
- acute adverse event rate
- late adverse event rate
- recurrence-free survival in affected breast
- deterioration of breast cosmetic outcomes rate
- disease-free survival
- overall survival
- local progression-free survival
- recurrence-free survival
- breast aggravation
研究者
相似试验
已完成
不适用
A clinical feasibility study to evaluate the effectiveness and safety of VivescOs™ as bone graft for reconstruction of intra-oral osseous defectsISRCTN92152389IsoTis NV (The Netherlands)10
招募中
2 期
A clinical, prospective feasibility study to assess the effectiveness and safety of micro-structured TCP granules as a bone augmentation material in sinus floor elevation procedures.NL-OMON32900niversitair Medisch Centrum Sint Radboud10
已完成
不适用
A prospective clinical study to evaluate the feasibility and safeness of the chemotherapy with weekly paclitaxel administration in cases with anaplastic thyroid cancerJPRN-UMIN000008574Anaplastic Thyroid Carcinoma Consortium Japan50
已完成
不适用
Feasibility study to evaluate the clinical outcome of the Scorpio knee prosthesis following THE LAZIRUSH CONCEPTKnee arthrosis10023213NL-OMON34366Stryker SA50
已完成
不适用
A clinical study to assess the feasibility of measuring inhaled medication concentrations in exhaled breath condensate obtained from healthy volunteers and asthma patients and to assess the relationship with clinical endpointsAsthmaasthmaNL-OMON46822Centre for Human Drug Research24